| __timestamp | Apellis Pharmaceuticals, Inc. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 2704597 |
| Thursday, January 1, 2015 | 13730311 | 15470000 |
| Friday, January 1, 2016 | 22978599 | 28037000 |
| Sunday, January 1, 2017 | 40303878 | 71615000 |
| Monday, January 1, 2018 | 105285576 | 99828000 |
| Tuesday, January 1, 2019 | 220968770 | 166023000 |
| Wednesday, January 1, 2020 | 299921000 | 201727000 |
| Friday, January 1, 2021 | 420869000 | 259039000 |
| Saturday, January 1, 2022 | 387236000 | 294781000 |
| Sunday, January 1, 2023 | 354387000 | 344077000 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Apellis Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc. have demonstrated significant growth in their R&D budgets, reflecting their dedication to advancing medical science.
From 2014 to 2023, Apellis Pharmaceuticals increased its R&D expenses by an impressive 4,100%, peaking in 2021. This surge underscores their aggressive pursuit of groundbreaking therapies.
Similarly, Iovance Biotherapeutics expanded its R&D spending by over 12,600% during the same period, with a notable rise in 2023, indicating a strategic focus on developing innovative cancer treatments.
Both companies exemplify the biotech sector's dynamic nature, where substantial R&D investments are pivotal for future breakthroughs.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
R&D Spending Showdown: Zoetis Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Biogen Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Incyte Corporation vs Apellis Pharmaceuticals, Inc.
Research and Development Investment: Lantheus Holdings, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Apellis Pharmaceuticals, Inc.
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Apellis Pharmaceuticals, Inc.
R&D Insights: How Apellis Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: Apellis Pharmaceuticals, Inc. and Galapagos NV
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Iovance Biotherapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Iovance Biotherapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?